Related references
Note: Only part of the references are listed.Microglial and macrophage polarization -new prospects for brain repair
Xiaoming Hu et al.
NATURE REVIEWS NEUROLOGY (2015)
Antiinflammatory Effects of Orientin-2-O-Galactopyranoside on Lipopolysaccharide-Stimulated Microglia
Xiang Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Microglia and inflammation: conspiracy, controversy or control?
Adelaide Fernandes et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
Hugo Gonzalez et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
1-O-Tigloyl-1-O-deacetyl-nimbolinin B Inhibits LPS-Stimulated Inflammatory Responses by Suppressing NF-κB and JNK Activation in Microglia Cells
Li Tao et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Microglial phagocytosis of live neurons
Guy C. Brown et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Sigma Receptor Ligand, (+)-Pentazocine, Suppresses Inflammatory Responses of Retinal Microglia
Jing Zhao et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity
Xing Fang et al.
ACTA PHARMACOLOGICA SINICA (2013)
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
Kenji Hashimoto
PROGRESS IN NEUROBIOLOGY (2013)
SKF83959 Is a Potent Allosteric Modulator of Sigma-1 Receptor
Lin Guo et al.
MOLECULAR PHARMACOLOGY (2013)
The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements
Arindam Pal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
Masuo Yamaoka et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Effects of the Sigma-1 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-Phenylpropyl)-Piperazine Dihydro-Chloride on Inflammation after Stroke
Karsten Ruscher et al.
PLOS ONE (2012)
Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection
M. D. Shenuarin Bhuiyan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
Teruo Hayashi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Neurosteroid Biosynthesis in the Brain of Amphibians
Hubert Vaudry et al.
Frontiers in Endocrinology (2011)
Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1
Jennifer V. Welser et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Pharmacology of signaling induced by dopamine D-1-like receptor activation
Ashiwel S. Undieh
PHARMACOLOGY & THERAPEUTICS (2010)
Sigma Receptors Suppress Multiple Aspects of Microglial Activation
Aaron A. Hall et al.
GLIA (2009)
Does neuroinflammation fan the flame in neurodegenerative diseases?
Tamy C. Frank-Cannon et al.
MOLECULAR NEURODEGENERATION (2009)
D5 Dopamine Receptors are Required for Dopaminergic Activation of Phospholipase C
Asha Sahu et al.
MOLECULAR PHARMACOLOGY (2009)
The pharmacology of sigma-1 receptors
Tangui Maurice et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Neuroprotective effects of atypical D1 receptor agonist SKf83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3β and a receptor-independent anti-oxidative action
Yang Yu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine
Sylvia B. Smith et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Neurotransmitter receptors on microglia
Jennifer M. Pocock et al.
TRENDS IN NEUROSCIENCES (2007)
Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1-specific ligand
Ying Dun et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease
Hai Zhang et al.
NEUROPHARMACOLOGY (2007)
Dual role of inflammation in CNS disease
Reinhard Hohlfeld et al.
NEUROLOGY (2007)
Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons
Yuling Ming et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Dehydroepiandrosterone (DHEA) metabolism in the brain: Identification by liquid chromatography/mass spectrometry of the delta-4-isomer of DHEA and related steroids formed from androstenedione by mouse BV2 microglia
PH Jellinck et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Dopamine and noradrenaline control distinct functions in rodent microglial cells
K Färber et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959
XC Zhen et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments
W Soudijn et al.
DRUG DISCOVERY TODAY (2004)
SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain
LQ Jin et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Role of p38 and p44/42 mitogen-activated protein kinases in microglia
M Koistinaho et al.
GLIA (2002)
SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
AR Cools et al.
NEUROPHARMACOLOGY (2002)
SKF83959 exhibits biochemical agonism by stimulating [35S]GTPγS binding and phosphoinositide hydrolysis in rat and monkey brain
S Panchalingam et al.
NEUROPHARMACOLOGY (2001)
Share Paper
